Loading…
STAAR Surgical Company is projected to rise to $28.36 by 2027, a +16% move from its current price of $24.36. STAA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $23.64 | $24.36 | $25.10 | 0.00% |
| Aug 3 | $23.35 | $24.36 | $25.42 | +0.01% |
| Aug 4 | $23.13 | $24.36 | $25.67 | +0.01% |
| Aug 5 | $22.94 | $24.36 | $25.87 | +0.02% |
| Aug 6 | $22.78 | $24.37 | $26.06 | +0.02% |
| Aug 7 | $22.64 | $24.37 | $26.23 | +0.03% |
| Aug 8 | $22.50 | $24.37 | $26.38 | +0.03% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $22.50 | $24.37 | $26.38 | +0.03% |
| Week 2 | $21.78 | $24.37 | $27.28 | +0.06% |
| Week 3 | $21.24 | $24.38 | $27.98 | +0.09% |
| Week 4 | $20.80 | $24.39 | $28.59 | +0.12% |
| Week 5 | $20.42 | $24.40 | $29.15 | +0.15% |
| Week 6 | $20.08 | $24.40 | $29.65 | +0.18% |
| Week 7 | $19.78 | $24.41 | $30.13 | +0.21% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
STAAR Surgical Company designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. It offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.
The company serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally.
STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
STAAR Surgical Company (STAA) operates in the Healthcare sector, focusing on implantable lenses and related delivery systems for refractive eye surgery. The stock carries a current price and market position that place it within a global healthcare devices niche with ophthalmic applications.
The current price is $23.97 and the market capitalization is $1.19B, with a rank of 2291. This provides a sense of its size and market position among listed securities.
Forecasts span 2026 through 2050, with the average price rising from $23.97 in 2026 to $199.93 in 2050 and a max of $409.69 by 2050. Sentiment in the forecast shifts from NEUTRAL in the near term (2026-2028) to BULLISH from 2029 onward.
A major floor 28.1% below — a decisive break under it would weaken the trend.
The nearest floor, 7.0% below — buyers have tended to step in here.
The nearest ceiling, 28.1% above — a clean break opens room to run.
A major ceiling 42.1% above — clearing it would confirm fresh momentum.
Key STAA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of STAA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $23.61 | Buy | $24.01 | Buy |
| MA 10 | $23.86 | Buy | $24.39 | Sell |
| MA 20 | $25.77 | Sell | $25.44 | Sell |
| MA 50 | $28.12 | Sell | $26.62 | Sell |
| MA 100 | $25.87 | Sell | $26.05 | Sell |
| MA 200 | $24.34 | Buy | $25.06 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.03 | Neutral |
| Stoch RSI (14) | 47.13 | Neutral |
| CCI (20) | -49.16 | Neutral |
| Williams %R (14) | -73.10 | Info |
| MACD (12,26,9) | -0.12 | Sell |
| ROC (12) | -14.53 | Sell |
| Bollinger %B (20,2) | 0.33 | Neutral |
| Stochastic %K (14) | 26.90 | Neutral |
| TRIX (15) | -0.63 | Sell |
| Awesome (5,34) | -3.45 | Sell |
| Ultimate (7,14,28) | 41.64 | Neutral |
| Momentum (10) | -2.08 | Sell |
| Aroon Osc (25) | -88.00 | Sell |
| Hull MA (9) | 23.86 | Buy |
| ADX (14) | 20.75 | Sell |
| ATR (14) | 0.69 | Info |
The 30-day technical picture is NEUTRAL, with RSI(14) at 30, indicating a neutral near-term stance. The 50-day simple moving average sits at $29.20 and the 200-day simple moving average at $24.47.
Near-term support is at $23.97 and resistance at $31.21. The 30-day price range runs from $19.00 to $30.25.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $16.10 | $24.36 | $30.74 | 0% | Neutral | |
| $22.41 | $28.36 | $38.07 | +16% | Neutral | |
| $21.90 | $28.61 | $40.00 | +17% | Neutral | |
| $22.37 | $29.99 | $43.28 | +23% | Bullish | |
| $30.09 | $41.27 | $61.17 | +69% | Bullish | |
| $33.21 | $46.51 | $70.55 | +91% | Bullish | |
| $34.11 | $48.71 | $75.42 | +100% | Bullish | |
| $36.51 | $53.11 | $83.77 | +118% | Bullish | |
| $35.07 | $51.91 | $83.30 | +113% | Bullish | |
| $38.20 | $57.50 | $93.74 | +136% | Bullish | |
| $52.80 | $85.79 | $149.44 | +252% | Bullish | |
| $103.55 | $192.21 | $368.50 | +689% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $16.10 | $24.36 | $28.38 | +0.00% |
| September 2026 | $20.20 | $23.97 | $29.31 | -1.58% |
| October 2026 | $20.45 | $24.45 | $30.24 | +2.00% |
| November 2026 | $20.04 | $24.10 | $30.09 | -1.43% |
| December 2026 | $20.18 | $24.42 | $30.74 | +1.29% |
Click any year to see its month-by-month STAA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, STAA is projected to trade between $16.10 and $30.74, averaging $24.36 — a potential gain of 0% from today's $24.36. Price action looks broadly range-bound.
STAAR Surgical Company's 2027 outlook centres on $28.36, within a $22.41 to $38.07 range. That is up +16% on the projected 2026 average. That marks a +16% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, STAA could reach as high as $40.00, with a base case around $28.61 and support toward $21.90 — roughly +17% from $24.36. Price action looks broadly range-bound.
Expect STAA to range from $22.37 to $43.28 through 2029. The $29.99 average target implies a +23% move from current prices. That is up +5% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The STAA price prediction for 2030 points to an average of $41.27 (low $30.09, high $61.17) — a potential gain of +69% on today's $24.36. Momentum favours further upside here.
In 2031, STAA is projected to trade between $33.21 and $70.55, averaging $46.51 — a potential gain of +91% from today's $24.36. That is up +13% on the projected 2030 average. Buyers look set to stay in control over this stretch.
STAAR Surgical Company's 2032 outlook centres on $48.71, within a $34.11 to $75.42 range. That is up +5% on the projected 2031 average. That marks a +100% change versus current levels. Momentum favours further upside here.
By 2033, STAA could reach as high as $83.77, with a base case around $53.11 and support toward $36.51 — roughly +118% from $24.36. Buyers look set to stay in control over this stretch.
Expect STAA to range from $35.07 to $83.30 through 2034. The $51.91 average target implies a +113% move from current prices. That is -2% versus the projected 2033 average. Momentum favours further upside here.
The STAA price prediction for 2035 points to an average of $57.50 (low $38.20, high $93.74) — a potential gain of +136% on today's $24.36. Buyers look set to stay in control over this stretch.
In 2040, STAA is projected to trade between $52.80 and $149.44, averaging $85.79 — a potential gain of +252% from today's $24.36. That is up +49% on the projected 2035 average. Momentum favours further upside here.
STAAR Surgical Company's 2050 outlook centres on $192.21, within a $103.55 to $368.50 range. That is up +124% on the projected 2040 average. That marks a +689% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in STAA today (≈ 41.050903 STAA) could be worth
$7,890.43
+$6,890.43 (+689%) by 2050 · US Dollar
Based on the average projected STAA price of $192.21 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in STAAwould be worth at today's price.
$1,000 invested in STAA on Jul 31, 2025 (≈ 55.803571 STAA) would be worth
$1,359.37
+$359.37 (+35.9%) today · 1.36× · US Dollar
Based on a STAA entry price of $17.92 vs. today's $24.36.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $23.38 | $1,041.92 | +4.2% |
| 1 month ago | $28.15 | $865.36 | -13.5% |
| 3 months ago | $27.19 | $895.92 | -10.4% |
| 6 months ago | $18.04 | $1,350.33 | +35.0% |
| 1 year ago | $17.92 | $1,359.37 | +35.9% |
| All time (5.0y) ago | $128.25 | $189.94 | -81.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our STAA forecast.
Our base-case forecast reaches $49.00 around 2033.
Implied market cap at $49.00: $2.44B
From 2026 to 2028, the forecast shows gradual gains: 2026 avg $23.97 (min $16.10, max $31.14, ROI 0, sentiment NEUTRAL); 2027 avg $27.83 (min $21.58, max $38.30, ROI 16.1, sentiment NEUTRAL); 2028 avg $27.36 (min $20.43, max $39.43, ROI 14.1, sentiment NEUTRAL).
From 2029 onward, the outlook becomes stronger: 2029 avg $29.40 (min $21.28, max $43.93, ROI 22.7, sentiment BULLISH); 2030 avg $41.79 (min $29.42, max $64.32, ROI 74.3, sentiment BULLISH); 2031 avg $46.45 (min $31.88, max $73.38, ROI 93.8, sentiment BULLISH); 2032 avg $48.91 (min $32.78, max $79.07, ROI 104.1, sentiment BULLISH); 2033 avg $53.21 (min $34.87, max $87.84, ROI 122, sentiment BULLISH); 2034 avg $50.57 (min $32.44, max $85.10, ROI 111, sentiment BULLISH); 2035 avg $57.34 (min $36.02, max $98.20, ROI 139.2, sentiment BULLISH).
The forecast continues with 2040 avg $83.33 (min $47.58, max $153.62, ROI 247.6, sentiment BULLISH) and 2050 avg $199.93 (min $96.17, max $409.69, ROI 734.1, sentiment BULLISH).
These numbers are estimates and not guarantees; actual results will vary with market conditions.
Tap a question to reveal the answer.
2030 avg $41.79; min $29.42; max $64.32; ROI 74.3; sentiment BULLISH.
Forecasts show Bullish sentiment from 2029 onward with average price rising to $41.79 by 2030 and $199.93 by 2050; max $409.69; ROI 734.1. These are estimates, not guarantees.
According to the forecast, the 2050 max is $409.69, with the 2050 average $199.93, indicating a potential above $100 in the long term.
The 30-day range is $19.00 to $30.25.
Current price is $23.97; market cap is $1.19B; rank 2291.
STAAR Surgical Company Community Discussion
0Share your STAAR Surgical Company price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.